Skip to content
★ Sign in to follow
유틸

유틸렉스 Stock: price and insider trades · South Korea

KR·Mcap ₩35.3BHealth Care

No insider purchase over the last 90 days. The latest, by 청안인베스트먼트, was filed 10 Dec 2025.

유틸렉스: what insiders have been doing

Every trade that managers of 유틸렉스 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 2 November 2026, brought 8 filings signed by 3 insiders.

On the market, 1 insider bought (1 purchase) while 1 insider sold (2 sales). The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The last purchase on record was published on 10 December 2025, which is 335 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

With 8 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. The full history, which starts in 2021, counts 6 purchases against 18 sales.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
70
Thresholds
n/a
Buy Volume
€7M
6 ops. · all time
Sell Volume
€11M
18 ops. · all time

Who traded when

BuySale
권병세3 sales
Kwon David Hyungjoong1 buy1 sale
Kwon Edwin Eujoong1 buy1 sale
Kwon Patrick Myungjoong1 buy1 sale
한명희1 buy1 sale
청안인베스트먼트1 buy
Fundamental score
Ranked 26,808 of 26,911 companies
4.1
score / 100
Value
4
Quality
4
FCF yld-42%
Earn yld-68%
EV/EBITDA·
ROE-102%
Gross mgn3.9%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩959
Analyst consensus
·
Income statement
Revenue₩10.3B
Gross profit₩404.7M4% margin
EBITDA-₩21.5B-209% margin
Net income-₩23.9B-265.4% margin
Valuation
Beta0.79
Balance sheet & cash
Market cap₩35.3B
Total debt₩15.5B
Free Cash Flow-₩14.7B
Debt / Equity138%
Profitability & ownership
ROE-102.3%
ROA-19.6%
% insiders20.0%
% institutions0.0%
Last declaration on 17 March 2026
Declarations71 total
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    €3.5Mest.0DART
    4,042,858 sharesKRXDART:20251210000001
    Canonical exit: 2 Mar 2026 (T+90)
  • ▼
    Executives
    €1.8Mest.0DART
    2,098,418 sharesKRXDART:20251208000368
  • ▼
    대표이사Executives(filed)
    €1.3Mest.0DART
    2,021,428 sharesShareKRXDART:20251208000287
  • ▼
    사실상지배주주Executives(filed)
    €513kest.0DART
    608,348 sharesShareKRXDART:20250522000358
  • ▼
    사실상지배주주Executives(filed)
    €513kest.0DART
    608,349 sharesShareKRXDART:20250522000361
  • ▼
    대량보유자Executives
    €3.0Mest.0DART
    3,548,849 sharesKRXDART:20250522000376
  • ▼
    사실상지배주주Executives(filed)
    €513kest.0DART
    608,348 sharesShareKRXDART:20250522000349
  • ▼
    사실상지배주주Executives(filed)
    €1.5Mest.0DART
    1,750,902 sharesShareKRXDART:20250522000339
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ▲
    사실상지배주주Executives(filed)
    €646kest.0DART
    755,976 sharesShareKRXDART:20250408003236
    Canonical exit: 7 Jul 2025 (T+90)
  • ▲
    사실상지배주주Executives(filed)
    €646kest.0DART
    755,976 sharesShareKRXDART:20250408003187
    Canonical exit: 7 Jul 2025 (T+90)
  • ▲
    사실상지배주주Executives(filed)
    €646kest.0DART
    755,976 sharesShareKRXDART:20250408003262
    Canonical exit: 7 Jul 2025 (T+90)
  • ▲
    사실상지배주주Executives(filed)
    €1.5Mest.0DART
    1,750,902 sharesShareKRXDART:20250408003154
    Canonical exit: 7 Jul 2025 (T+90)
  • ▲
    대표이사Executives(filed)
    €59kest.0DART
    35,998 sharesShareKRXDART:20241104000342
    Canonical exit: 2 Feb 2025 (T+90)
  • ▼
    감사Executives
    0DART
    ShareKRXDART:20240926000386
  • ▼
    감사Executives
    0DART
    ShareKRXDART:20240726000433

25 of 71 declarations

About 유틸렉스

Utillex is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the treatment of various diseases.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations